Caribou Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | — | — | $41.1M |
| FY2020 | $18.2M | $36.0M | $16.0M |
| FY2021 | $54.5M | $442.4M | $240.4M |
| FY2022 | $72.9M | $373.8M | $58.3M |
| FY2023 | $63.8M | $432.2M | $51.2M |
| FY2024 | $60.4M | $313.3M | $16.3M |
| FY2025 | $53.2M | $175.4M | $12.4M |